Kyri K. Van Hoose

CFO

US·SEC (Form 4)

Dermata Therapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 18 Aug 2026 for Dermata Therapeutics, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Kyri K. Van Hoose: trading record in brief

Kyri K. Van Hoose discloses dealings in Dermata Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 21 January 2025 to 16 August 2026, the count stands at 3 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 18 August 2026 came the latest disclosure, a share grant in Dermata Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.